- Review risk factors for pediatric type 2 diabetes
- Discuss screening approaches, including potential pitfalls and cost effectiveness
- Review management and a new medication option for pediatric type 2 diabetes
Pediatric type 2 diabetes is rising in incidence, most notably in racial/ethnic minorities. It is associated with high rates of comorbidities and complications soon after diagnosis, and early recognition and treatment may improve outcomes. This talk will review which pediatric patients are at highest risk for type 2 diabetes, how and when to screen, and what to do if type 2 diabetes is diagnosed.
Mary E. Vajravelu, MD, is a pediatric endocrinologist in the Division of Endocrinology at Children's Hospital of Philadelphia.
ACCME Accreditation Statement: Children’s Hospital of Philadelphia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement: Children's Hospital of Philadelphia designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement: Mary Vajravelu, MD (Speaker), Lisa Biggs, MD (CHOP Talks Course Director) and Monica S. Williams (CME Planner) and others as appropriate have no relevant financial relationship with a commercial interest to disclose.